SANUWAVE Health, Inc.
Data quality: 100%
SNWV
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$16.84
▼
$1.32
(-7.27%)
Mkt Cap: 155.56 M
Price
$18.10
Mkt Cap
155.56 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Revenue grew 35.65% annually over 5 years — strong growth
Net margin of 26.82% shows strong profitability
Generating 1.93 M in free cash flow
P/E of 13.17 — trading at a low valuation
Capital efficient — spends only 4.41% of revenue on capex
ROIC of 382.49% — excellent capital efficiency
Growth
Revenue Growth (5Y)
35.65%
Above sector avg (1.82%)
Revenue (1Y)34.98%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC382.49%
Net Margin26.82%
Op. Margin11.23%
Safety
Debt / Equity
N/A
Current Ratio1.16
Interest Coverage0.88
Valuation
PE (TTM|2027)
13.17 | 18.76
Above sector avg (-1.47)
P/B RatioN/A
EV/EBITDA28.59
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 13.2 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.3 |
| Net Margin % | 26.8 | -41.5 |
| Rev Growth 5Y % | 35.7 | 1.8 |
| D/E | — | 0.3 |
Analyst Price Target
2 analysts
Buy
Current
$16.84
Target
$43.50
$40.00
$43.50
$47.00
Forecast
Forward P/E
17.45
Forward EPS
$0.97
EPS Growth (est.)
+141.3%
Est. Revenue
65.34 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.97
$0.37 – $1.56
|
65.34 M | 2 |
| FY2026 |
$0.40
-$0.06 – $0.86
|
52.07 M | 2 |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 |
$0.05
-$0.03 – $0.13
|
11.51 M | 2 |
| 2026 Q1 |
-$0.04
-$0.12 – $0.05
|
9.84 M | 2 |
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q42025 | $0.17 | $0.03 | -82.4% |
| Q32025 | $0.32 | $0.46 | +43.8% |
| Q22025 | -$0.09 | $0.01 | +111.1% |
| Q12025 | N/A | -$0.66 | — |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 34.98% | Revenue Growth (3Y) | 46.95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 35.65% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 44.05 M | Net Income (TTM) | 11.81 M |
| ROE | N/A | ROA | 34.42% |
| Gross Margin | 77.11% | Operating Margin | 11.23% |
| Net Margin | 26.82% | Free Cash Flow (TTM) | 1.93 M |
| ROIC | 382.49% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.16 |
| Interest Coverage | 0.88 | Asset Turnover | 1.28 |
| Working Capital | 3.06 M | Tangible Book Value | -13.39 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 13.17 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 3.53 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 28.59 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 1.24% | ||
| Market Cap | 155.56 M | Enterprise Value | 169.24 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.41 | Revenue / Share | 5.13 |
| FCF / Share | 0.23 | OCF / Share | 0.45 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 4.41% | FCF Conversion | 16.37% |
| SBC-Adj. FCF | -1.58 M | Growth Momentum | -0.67 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 44.05 M | 32.63 M | 20.40 M | 16.74 M | 13.01 M |
| Net Income | 11.81 M | -31.37 M | -25.81 M | -10.29 M | -27.26 M |
| EPS (Diluted) | 0.41 | -7.03 | -0.03 | -0.02 | -0.05 |
| Gross Profit | 33.97 M | 24.55 M | 14.36 M | 12.41 M | 8.02 M |
| Operating Income | 4.95 M | 5.42 M | -540,000.0 | -8.95 M | -14.14 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 1.35 M | 673,000.0 | 579,000.0 | 567,000.0 | 1.10 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 974,000.0 | 1.15 M | 1.03 M | 952,000.0 | 532,000.0 |
| Interest Expense | 5.64 M | — | — | 12.77 M | 6.88 M |
| Income Tax | 86,000.0 | 27,000.0 | 4,000.0 | 2,000.0 | 28,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 37.34 M | 30.12 M | 22.42 M | 19.87 M | 18.62 M |
| Total Liabilities | 35.72 M | 42.84 M | 65.59 M | 60.88 M | 57.58 M |
| Shareholders' Equity | 1.62 M | -12.72 M | -43.18 M | -41.01 M | -38.96 M |
| Total Debt | 21.89 M | — | — | 1.48 M | 26.26 M |
| Cash & Equivalents | 11.96 M | 10.24 M | 1.80 M | 1.15 M | 619,000.0 |
| Current Assets | 24.63 M | 18.40 M | 9.78 M | 6.62 M | 4.40 M |
| Current Liabilities | 17.85 M | 42.35 M | 64.76 M | 60.19 M | 56.26 M |
{"event":"ticker_viewed","properties":{"ticker":"SNWV","listing_kind":"stock","pathname":"/stocks/snwv","exchange":"Nasdaq","country":"US"}}